Upjohn SRL
The score of Upjohn shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -27 % Total assets -51 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Upjohn's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Jul 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
- Year ended 31 Dec 2022filed on 03 Aug 2023
- Year ended 30 Nov 2021filed on 09 Jun 2022
Upjohn's financial analysis
- Solvency98.0%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Upjohn
Upjohn's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0552.558.025
- VAT number
- BE0552558025
- Peppol
- Registered · 0208:0552558025 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 May 2014
- Registered office
- 1560 Hoeilaart
- Latest accounts
- 2025 · filed on 07 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Upjohn (SRL) has been based in Hoeilaart since 2014, active in: manufacture of medicaments. For 2025, it reports a net profit of 850,025 € and equity of €12.1m; its revenue is not published. Its solvency stands at 98.0%, above the median of its sector (47.2%).
Companies similar to Upjohn
Companies in the same business, of comparable size and area, outside its group.
- BePharBel Manufacturing Manufacture of basic pharmaceutical products Courcelles · balance sheet €27.4m
- Norgine Wholesale of pharmaceutical and medical goods Leuven · balance sheet €14.1m
- Will - Pharma Manufacture of pharmaceutical preparations Wavre · balance sheet €9.73m
- White Raven Manufacture of pharmaceutical preparations Liège · balance sheet €9.55m
- S.A. Laboratoires Pharmaceutiques Trenker Manufacture of basic pharmaceutical products Nivelles · balance sheet €16.1m
- Exphar Wholesale of pharmaceutical and medical goods Nivelles · balance sheet €14.1m
- FertiPro Manufacture of other chemical products n.e.c. Beernem · balance sheet €15.9m
- Conforma Manufacture of pharmaceutical preparations Destelbergen · balance sheet €16.3m
Frequently asked questions about Upjohn
What is the revenue of Upjohn?
Upjohn files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Upjohn?
In Belgium, the VAT number is the company number prefixed with BE: BE0552558025 for Upjohn, if the company is VAT-registered. Its company number (CBE) is 0552.558.025.
Where is the registered office of Upjohn?
According to the CBE register, the registered office of Upjohn is in 1560 Hoeilaart.
What is the equity of Upjohn?
At the close of the 2025 financial year, the equity of Upjohn amounts to 12,096,522 €, a solvency of 98.0% of total assets.
Who manages Upjohn?
The register lists 2 active mandates at Upjohn. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Upjohn
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →